Opportunistic Osteoporosis Assessment from Routine CT - Effect of Intravenous Contrast Agents on Absolute Values, T-Scores, and Derived Classifications in Single- and Dual-Energy CT
Author Block: L. D. Grünewald, V. Koch, S. Mahmoudi, J-E. Scholtz, S. Martin, C. Booz, I. Yel, T. Vogl; Frankfurt/DE
Purpose: To evaluate the impact of intravenous contrast agents on osteoporosis assessment via routine CT in arterial and venous phases and identify mitigation strategies using dual-energy CT (DECT).
Methods or Background: 288 patients (154 men, 134 women; median age 62 years) who underwent abdominal DECT scans in non-contrast, late-arterial, and portal venous phases between January 2018 and December 2023 were retrospectively analyzed. Trabecular HU values were measured in all phases, including 90kV and 150kV DECT series, using automatic segmentation. T-scores were calculated to classify patients as osteoporotic, osteopenic, or normal. Changes in HU values, T-scores, and classifications due to contrast were compared to non-contrast images, with effects quantified using Cohen’s d.
Results or Findings: Median trabecular HU at L1 was 147 (IQR 116–185). Contrast in late arterial and portal venous phases increased HU values by +14.4 (+11.2%) and +25.7 (+20.7%), respectively. Using 150kV DECT reduced these changes to -20.5 (-12.2%) for arterial and -23.15 (-12.6%) for venous phases. Cohen’s d was lowest for normal arterial phase (+0.55) and highest for 90kV arterial phase (+1.9). Based on T-scores, 120 patients were classified as healthy, 108 as osteopenic, and 60 as osteoporotic. The lowest number of reclassifications occurred in arterial (n=92) and venous (n=104) phases. For arterial phase, 44 patients shifted from osteoporosis to osteopenia; for venous phase, 52 shifted similarly. High-kV acquisition reduced these reclassifications (n=24 arterial, n=32 venous) but increased shifts from healthy to osteopenia.
Conclusion: Intravenous contrast significantly affects HU-based osteoporosis assessment, leading to reclassifications, especially from osteopenia to healthy. Using 150kV DECT can partially reduce these reclassifications, though it may incorrectly shift healthy cases toward osteopenia.
Limitations: Modifying kV settings is not immediately possible without dedicated equipment
Funding for this study: No funding was received for this study
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: Consent waived due to retrospective nature